Official UK procurement notice
Supply of Colchicine · UK public procurement notice
Authority: Department of Health & Social Care (Central government)
What is being bought
Published requirement descriptionThe Department of Health and Social Care (DHSC) has awarded a contract for the supply of Colchicine for Covid-19.
CPV: Pharmaceutical products
The lotProcurement structure
single lot · no lot value publishedLot #1The Department of Health and Social Care conducted a negotiated procedure without…Awarded
The Department of Health and Social Care conducted a negotiated procedure without prior publication under the Public Contracts Regulations 2015 (as amended) for the supply of Colchicine 500mcg tablets. The contract period expires on 12 April 2021.
Procedure terms & legal framework
From the official record- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 7 Apr 2021, 17:02 BST
- Last source update
- 7 Apr 2021, 17:02 BST
- Authority reference
CM/EMP/21/25161- FTS notice number
2021/S 000-007139- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-02a354Find a Tender
- Why no open competition
Extreme urgency brought about by events unforeseeable for the contracting authority/entity and in accordance with the strict conditions stated in the directive
- Published justification
The Coronavirus disease (COVID-19) gave rise to an extremely urgent need for the Authority to purchase a quantity of Colchicine because the Authority needs to be in a position to treat the population as required such that did not give the Authority sufficient time to comply with the standard Open Procedure time scales for this procurement. Accordingly, the Authority used the negotiated procedure without prior publication – Regulation 32(2)(c) – Extreme Urgency Route (i.e. direct award) permitted under the Public Contract Regulations 2015 (as amended) to conduct this procurement. It was imperative to maintain security of supply for public health purposes in the face of high global demand. In these circumstances, a procurement following the usual timescales under the PCR 2015, including accelerated options, was not feasible in order for the DHSC to secure the urgent supply of the Colchicine.
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| ACCORD-UK LTD | £222,480 † | — | Awarded |
| HFA Healthcare Products Ltd | £174,350 † | — | Awarded |
| Sigma Pharmaceuticals plc | £9,940 † | — | Awarded |
| Morningside (Leicester) Limited | £154,500 † | — | Awarded |
| Vertical Pharma Resources Ltd | £50,297 † | — | Awarded |
Contracts
Contract 007139-2021-1 · ACCORD-UK LTD
- Signed
- 8 Mar 2021
- Value
- £222,480
- Status
- active
Contract 007139-2021-2 · HFA Healthcare Products Ltd
- Signed
- 8 Mar 2021
- Value
- £174,350
- Status
- active
Contract 007139-2021-3 · Sigma Pharmaceuticals plc
- Signed
- 8 Mar 2021
- Value
- £9,940
- Status
- active
Contract 007139-2021-4 · Morningside (Leicester) Limited
- Signed
- 8 Mar 2021
- Value
- £154,500
- Status
- active
Contract 007139-2021-5 · Vertical Pharma Resources Ltd
- Signed
- 8 Mar 2021
- Value
- £50,297
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 5bids | — | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- The High CourtReview body
Bidders & participating suppliers
5 commercial parties on the notice- Accord-UK LtdAwarded supplier
- HFA Healthcare Products LimitedAwarded supplier
- Morningside Pharmaceuticals LtdAwarded supplier
- Sigma Pharmaceuticals plcAwarded supplier
- Vertical Pharma Resources LimitedAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.